U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H12ClN3O3
Molecular Weight 293.706
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of KR-32570

SMILES

COC1=CC=C(Cl)C=C1C2=CC=C(O2)C(=O)NC(N)=N

InChI

InChIKey=DYGXZBQDLFYIFD-UHFFFAOYSA-N
InChI=1S/C13H12ClN3O3/c1-19-9-3-2-7(14)6-8(9)10-4-5-11(20-10)12(18)17-13(15)16/h2-6H,1H3,(H4,15,16,17,18)

HIDE SMILES / InChI

Molecular Formula C13H12ClN3O3
Molecular Weight 293.706
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Antiplatelet activity of [5-(2-methoxy-5-chlorophenyl)furan-2-ylcarbonyl]guanidine (KR-32570), a novel sodium/hydrogen exchanger-1 and its mechanism of action.
2006 May
Patents

Patents

Substance Class Chemical
Created
by admin
on Sat Dec 16 09:49:42 GMT 2023
Edited
by admin
on Sat Dec 16 09:49:42 GMT 2023
Record UNII
31SF23L56C
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
KR-32570
Common Name English
2-FURANCARBOXAMIDE, N-(AMINOIMINOMETHYL)-5-(5-CHLORO-2-METHOXYPHENYL)-
Systematic Name English
(5-(2-METHOXY-5-CHLORO-5-PHENYL)FURAN-2-YLCARBONYL)GUANIDINE
Systematic Name English
Code System Code Type Description
FDA UNII
31SF23L56C
Created by admin on Sat Dec 16 09:49:43 GMT 2023 , Edited by admin on Sat Dec 16 09:49:43 GMT 2023
PRIMARY
CAS
851982-20-2
Created by admin on Sat Dec 16 09:49:43 GMT 2023 , Edited by admin on Sat Dec 16 09:49:43 GMT 2023
SUPERSEDED
CAS
852146-75-9
Created by admin on Sat Dec 16 09:49:43 GMT 2023 , Edited by admin on Sat Dec 16 09:49:43 GMT 2023
PRIMARY
PUBCHEM
11403628
Created by admin on Sat Dec 16 09:49:43 GMT 2023 , Edited by admin on Sat Dec 16 09:49:43 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY